Williamson Legacy Group LLC Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Williamson Legacy Group LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,193 shares of the medical equipment provider’s stock after purchasing an additional 93 shares during the quarter. Williamson Legacy Group LLC’s holdings in Intuitive Surgical were worth $623,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of ISRG. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical in the 4th quarter worth $28,000. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the 3rd quarter worth $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical in the 4th quarter worth $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical in the 3rd quarter worth $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $573.15 on Friday. The company has a market capitalization of $204.14 billion, a P/E ratio of 89.42, a P/E/G ratio of 5.85 and a beta of 1.39. The company’s 50-day simple moving average is $569.87 and its two-hundred day simple moving average is $528.64. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,077 shares of company stock worth $4,620,025 in the last three months. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on ISRG. Citigroup boosted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Truist Financial upped their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research report on Friday, January 24th. CICC Research started coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price on the stock. BTIG Research upped their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Finally, Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.